Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

OPINIONS

 b-of-a-securities-maintains-underperform-on-ambarella-lowers-price-target-to-70

B of A Securities analyst Vivek Arya maintains Ambarella (NASDAQ:AMBA) with a Underperform and lowers the price target from ...

 top-5-materials-stocks-youll-regret-missing-this-quarter

The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.

 b-of-a-securities-maintains-underperform-on-c3ai-raises-price-target-to-18

B of A Securities analyst Brad Sills maintains C3.ai (NYSE:AI) with a Underperform and raises the price target from $16 to $18.

Core News & Articles
High-Impact Movers for June 1st
06/01/2023 12:51:15

UCAR - 63% - U Power Limited Enters into Framework Strategic Cooperation Agreement with Quantum Solutions Co., Ltd. in JapanMNP...

Core News & Articles

Corebridge Financial, Inc. (NYSE:CRBG) ("Corebridge" or the "Company") today announced that its Board of Direct...

 guggenheim-maintains-buy-on-capri-holdings-lowers-price-target-to-51

Guggenheim analyst Robert Drbul maintains Capri Holdings (NYSE:CPRI) with a Buy and lowers the price target from $61 to $51.

 neurosense-provides-business-update-phase-2b-als-trial-completes-enrollment-topline-data-expected-q4-2023

 NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerativ...

 neurosense-therapeutics-q1-eps-033-down-from-024-yoy

NeuroSense Therapeutics (NASDAQ:NRSN) reported quarterly losses of $(0.33) per share. This is a 37.5 percent decrease over loss...

 ubs-maintains-buy-on-crowdstrike-holdings-raises-price-target-to-170

UBS analyst Fatima Boolani maintains CrowdStrike Holdings (NASDAQ:CRWD) with a Buy and raises the price target from $165 to ...

 southwest-airlines-provides-updated-guidance-sees-q2-economic-fuel-costs-per-gallon-up-255-vs-245-255-previous-est--revenue-per-available-seat-mile-yoy-down-8-10-vs-down-8-11-previous-est

Southwest Airlines Co. (NYSE:LUV) (the "Company") is providing updated guidance regarding selected financial trends. T...

 european-central-banks-villeroy-says-we-will-bring-inflation-to-2-by-2025

- Reuters  - Reuters  

 ubs-maintains-sell-on-chewy-raises-price-target-to-26

UBS analyst Joseph Parkhill maintains Chewy (NYSE:CHWY) with a Sell and raises the price target from $24 to $26.

Core News & Articles

Macy's (M) - Shares fell premarket after the company lowered its FY23 financial outlook, noting dema...

 booming-adp-employment-stable-unemployment-claims-set-stage-for-fridays-key-may-jobs-report

The American labor market continues to demonstrate its strength, with the ADP reporting Thursday a notable and better-than-expe...

 ubs-upgrades-csx-to-buy-raises-price-target-to-37

UBS analyst Thomas Wadewitz upgrades CSX (NASDAQ:CSX) from Neutral to Buy and raises the price target from $33 to $37.

 european-central-banks-villeroy-says-upcoming-rate-hikes-will-be-marginal

- Reuters  - Reuters  

 european-central-banks-villeroy-says-rate-hikes-are-starting-to-have-impact-on-inflation

- Reuters- Reuters

NEW CASE INVESTIGATION

CORE Finalist